A potential approval of the vaccine would boost the country's immunization drive and help allay fears of parents anxious to protect their children from COVID-19. Moderna Inc and Johnson & Johnson are also testing their vaccines in 12- to 18-year olds, with data from Moderna's trial expected to come soon. Pfizer and Moderna have also launched trials in even younger children, aged six months to 11 years old. Both companies have said they hope to be able to vaccinate children under 11 as soon as early 2022. Israel braced Following Pfizer's clinic trials in March, the Israel Pediatric Association recommended vaccinating this age group as soon as FDA approval is finalized.